Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA delays decision on Biogen's multiple sclerosis drug
FDA delays decision on Biogen's multiple sclerosis drug
FDA delays decision on Biogen's multiple sclerosis drug
Submitted by
admin
on March 18, 2014 - 8:58am
Source:
Yahoo/Reuters
News Tags:
FDA
Plegridy
Biogen Idec
MS
multiple sclerosis
Headline:
FDA delays decision on Biogen's multiple sclerosis drug
Do Not Allow Advertisers to Use My Personal information
